| Richard M Lewis, MD | |
|
12221 Mopac Expressway North, Austin, TX 78758-2483 | |
| (512) 901-4019 | |
| (512) 901-3919 |
| Full Name | Richard M Lewis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 12221 Mopac Expressway North, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598726408 | NPI | - | NPPES |
| P00474051 | Other | TX | RR MEDICARE |
| 129523006 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | H1615 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard M Lewis, MD 12221 Mopac Expressway North, Austin, TX 78758-2483 Ph: (512) 901-4019 | Richard M Lewis, MD 12221 Mopac Expressway North, Austin, TX 78758-2483 Ph: (512) 901-4019 |
News Archive
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Cardiovascular diseases (CVDs) are the leading cause of death globally. Monitoring of lipid in patients with coronary heart disease (CHD) is important for decreasing the incidence of cardiovascular events.
The TriZetto Group, Inc. today announced that Hallmark Insights, a wholly owned subsidiary of Hallmark Cards, Inc., will provide incentive rewards as an integrated component of TriZetto's Value-Based Benefits Solution for healthcare payer organizations. Available in early 2010, TriZetto's software solution will enable health plans using TriZetto's enterprise administration systems to offer employers automated benefit programs that incent members to adopt healthier lifestyles and effectively manage chronic conditions.
› Verified 4 days ago
Dr. Tatiana B. Jacobson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Caves Rd. Bldg C Ste. 102, Austin, TX 78746 Phone: 512-323-5465 Fax: 512-327-1390 | |
Preeti Venkatraman, M.B.B.S. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 601 E 15th St, Austin, TX 78701 Phone: 512-324-7000 | |
Pritesh Harish Gandhi, M.D., M.P.H. Nephrology Medicare: Medicare Enrolled Practice Location: 1101 Camino La Costa, Austin, TX 78752 Phone: 512-684-1832 | |
Dr. Joshua Lane Davis, D.O. Nephrology Medicare: Medicare Enrolled Practice Location: 1004 W 32nd St Unit 300, Austin, TX 78705 Phone: 512-324-3440 | |
Dr. Analicia Alvarado, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1500 Red River St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Grace Marie Grant-jennings, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7000 North Mopac, Suite # 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Dr. Debra Ann Patt, MD, MPH Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6204 Balcones Dr, Austin, TX 78731 Phone: 512-427-9400 Fax: 512-342-2723 |